- Home
- DIT vs BYSI Comparison
DIT vs BYSI Comparison
Compare DIT & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- BYSI
- Stock Information
- Founded
- DIT 1981
- BYSI 2010
- Country
- DIT United States
- BYSI United States
- Employees
- DIT N/A
- BYSI N/A
- Industry
- DIT Food Distributors
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- BYSI Health Care
- Exchange
- DIT Nasdaq
- BYSI Nasdaq
- Market Cap
- DIT 78.7M
- BYSI 72.1M
- IPO Year
- DIT 1995
- BYSI 2017
- Fundamental
- Price
- DIT $106.60
- BYSI $1.60
- Analyst Decision
- DIT
- BYSI
- Analyst Count
- DIT 0
- BYSI 0
- Target Price
- DIT N/A
- BYSI N/A
- AVG Volume (30 Days)
- DIT 218.0
- BYSI 24.2K
- Earning Date
- DIT 04-18-2025
- BYSI 01-01-0001
- Dividend Yield
- DIT 0.92%
- BYSI N/A
- EPS Growth
- DIT N/A
- BYSI N/A
- EPS
- DIT 2.44
- BYSI N/A
- Revenue
- DIT $2,221,421,072.00
- BYSI N/A
- Revenue This Year
- DIT N/A
- BYSI N/A
- Revenue Next Year
- DIT N/A
- BYSI N/A
- P/E Ratio
- DIT $47.91
- BYSI N/A
- Revenue Growth
- DIT 7.47
- BYSI N/A
- 52 Week Low
- DIT $99.87
- BYSI $0.98
- 52 Week High
- DIT $174.99
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- DIT 34.75
- BYSI 60.39
- Support Level
- DIT $99.87
- BYSI $1.31
- Resistance Level
- DIT $123.98
- BYSI $1.67
- Average True Range (ATR)
- DIT 4.23
- BYSI 0.13
- MACD
- DIT -0.54
- BYSI 0.06
- Stochastic Oscillator
- DIT 27.86
- BYSI 89.34
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.